Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.53%
Dec 31, 2025 -48.60%
Sep 30, 2025 -34.71%
Jun 30, 2025 1.57%
Mar 31, 2025 23.46%
Dec 31, 2024 27.44%
Sep 30, 2024 13.92%
Jun 30, 2024 -18.16%
Mar 31, 2024 43.11%
Dec 31, 2023 37.56%
Sep 30, 2023 55.24%
Jun 30, 2023 38.17%
Mar 31, 2023 -11.92%
Dec 31, 2022 -186.85%
Sep 30, 2022 53.63%
Jun 30, 2022 -12.20%
Mar 31, 2022 -522.67%
Dec 31, 2021 -22.14%
Sep 30, 2021 -80.20%
Jun 30, 2021 -22.03%